drugset

drugset / Trial / NCT02865005

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

NCT02865005 ↗

Phase 3 Completed 2361 enrolled Seegpharm S.A.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Multi-center, double-blind, randomized, placebo-controlled trial of Dapsone 5.0% Gel in the treatment of acne vulgaris.

Timeline

Start: 2016-02
Primary completion: 2016-11
Completion: 2016-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Dapsone	Small molecule	5 %	Topical

Indications